You are here
CAMBRIDGE SCIENTIFIC, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Biopolymeric Strength Augmenation to the Spine
Amount: $100,000.00DESCRIPTION (provided by applicant): Spinal fusion is the most common type of bone grafting procedure. Despite the continuing evolution of devices designed to aid in interbody fusion, nonunion remains ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Biodegradable Bone Graft Extender
Amount: $750,001.00DESCRIPTION (provided by applicant): In order to expand upon the clinical utility of bone replacement materials, Cambridge Scientific, Inc proposes to develop a biodegradable bone graft extender that ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
Biodegradable Bone Graft Extender
Amount: $0.00DESCRIPTION (provided by applicant): In order to expand upon the clinical utility of bone replacement materials, Cambridge Scientific, Inc proposes to develop a biodegradable bone graft extender that ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
DNA PLASMID MUCOSALLY ENHANCED ANTHRAX DELIVERY VACCINE
Amount: $125,002.00DESCRIPTION (provided by applicant): Mucous membranes are the primary routes of entry for a variety of disease carrying agents, including anthrax. Many human pathogens enter and replicate at the muco ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
Enhancing Malaria Vaccine Development by the Navy Medical Research Center
Amount: $741,236.00"The goal of the Phase II project will be to optimize a PLGA form for clinical trials based on characterization of the dose/response of the particulate in small and large animal models. The particular ...
SBIRPhase II2002Department of Defense Navy -
Enhancing Malaria Vaccine Development by the Navy Medical Research Center
Amount: $0.00"The goal of the Phase II project will be to optimize a PLGA form for clinical trials based on characterization of the dose/response of the particulate in small and large animal models. The particular ...
SBIRPhase I2002Department of Defense Navy -
SOLUBLE CALCIUM ORGANIC SALTS IN RESORBABLE BONE CEMENT
Amount: $0.00N/A
SBIRPhase I2001Department of Health and Human Services National Institutes of Health -
SOLUBLE CALCIUM ORGANIC SALTS IN RESORBABLE BONE CEMENT
Amount: $425,249.00N/A
SBIRPhase II2001Department of Health and Human Services National Institutes of Health -
Implantable Hepatocyte Culture on 3-D Biopolymers
Amount: $100,000.00Acute and chronic liver dysfunction cause approximately 30,000 deaths yearly. Limited supplies of donor organs allow only about 3000 transplants per year. Techniques for temporary liver function repla ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health -
NANO-HYDROXYAPATITE IN BIOPOLYMERIC SCAFFOLDS FOR BONE
Amount: $151,906.00DESCRIPTION: Many new polymer systems are being developed to accommodate biomaterial needs bone reconstruction. However, despite significant advances in the development of newer tissu ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health
